Telswit‑40 Tablets consist of Telmisartan I.P. 40 mg, a long-acting angiotensin II receptor blocker (ARB). It effectively lowers systemic blood pressure by inhibiting angiotensin II–induced vasoconstriction and sodium retention. Telmisartan’s extended half-life supports once-daily dosing and provides sustained therapeutic coverage.
Consistent blood pressure control without peak-trough fluctuations
Protective effects on heart and kidneys, especially in diabetic patients
Good tolerability and metabolic neutrality
Essential hypertension, alone or add-on therapy
Prevention of cardiovascular events in hypertensive patients
One tablet daily, with or without food. Dose adjustment may be required based on response.
Monitor renal function and electrolytes
Avoid in pregnancy, lactation, or bilateral renal artery stenosis
Side effects may include dizziness, fatigue, or mild gastrointestinal symptoms
Store in a cool, dry place below 25 °C and keep out of reach of children.
Telswit‑40 provides a reliable, long-acting ARB to help keep blood pressure under control and lower cardiovascular risk.
